Avacincaptad Pegol
Brand Names: Izervay
Methodology & AI Transparency ⓘ
Avacincaptad Pegol Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Listed in the U.S.
- 2 Real-world patient consensus: Tracked across 5 patient dosage logs with a 88% satisfaction benchmark (RxCUI RXN-82829002-2464).
- 3 Typical cash cost range: Dispensing cost comparison spans $29.56 mail/discount cash up to $72.42 uninsured retail (federal NADAC $0.5200).
- 4 Top reported side effects / signs: Most commonly reported Avacincaptad Pegol tolerability events: nausea (7.4%), headache (6.5%), dizziness (4.8%).
Ask our AI Specialists anything about Avacincaptad Pegol
Avacincaptad Pegol Mechanism, CYP450 Pathways & DailyMed Monograph
Listed in the U.S. FDA National Drug Code Registry (82829-002), Avacincaptad Pegol serves as a intravitreal-route prescription complement inhibitor (20 mg/mL Injection, manufactured/labeled by Astellas Pharma US, Inc.) utilized in evidence-based specialty and primary care protocols.
Upon intravitreal-route administration of 20 mg/mL Injection, Avacincaptad Pegol (manufactured/labeled by Astellas Pharma US, Inc.; NDC 82829-002) engages complement inhibitor biochemical pathways to achieve steady-state therapeutic response balanced against organ-specific metabolic elimination.
With Biphasic clearance with 8–19 hr terminal t½ under Avacincaptad Pegol maintenance residence kinetics and Complete (~100%) parenteral systemic delivery for Avacincaptad Pegol (20 mg/mL Injection) bioavailability, Avacincaptad Pegol undergoes hepatic enzymatic processing and renal clearance proportional to creatinine clearance (avacincaptad pegol) and establishes therapeutic activity over rapid intravascular/parenteral onset within 15–45 minutes after avacincaptad pegol administration.
Standard adult regimens span 20 mg/mL Injection, 20 mg/mL. Prescribers screen specifically against documented intolerance or hypersensitivity reaction involving avacincaptad pegol (complement inhibitor); concurrent restricted medications flagged in section 4/7 of the avacincaptad pegol dailymed monograph (rxn-82829002-2464), while community micro-logs most frequently note nausea (7.4% of reports), headache (6.5% of reports), fatigue (5.3% of reports).
Assess baseline hepatic panels and interacting prescriptions when starting Avacincaptad Pegol (complement inhibitor).
Shifts in intragastric pH can modestly influence dissolution kinetics of oral Avacincaptad Pegol dosage forms.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Documented intolerance or hypersensitivity reaction involving Avacincaptad Pegol (complement inhibitor)
- Concurrent restricted medications flagged in Section 4/7 of the Avacincaptad Pegol DailyMed monograph (RXN-82829002-2464)
Logged Side-Effect Incidence (5 Reports)
Avacincaptad Pegol Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Avacincaptad Pegol)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular: What a 286-Participant Study Found Intravitreal administration of avacincaptad pegol 2 mg and 4 mg led to a significant reduction of GA growth in eyes with AMD over a 12-month period. Ophthalmology • 2021-04-15 • Phase III Randomized Trial | N = 286 | 87/100 | PMID 32882310 ↗ |
| Can This Approach Help? Inside the Latest Research on Avacincaptad Pegol Slows Progressive Ellipsoid Zone Degradation and Loss in Eyes Greater baseline total and partial EZ attenuation were associated with higher rates of GA growth and progressive EZ loss over time, establishing these EZ measures as important predictors of future GA growth and photoreceptor loss. Ophthalmology • 2026-11-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 42379522 ↗ |
| New Insights on Vision Loss Reduction with Avacincaptad Pegol for Geographic Atrophy: A 12-Month: What a 225-Participant Study Found Treatment with ACP 2 mg delayed the risk of progression to persistent vision loss (i.e., ≥10-, ≥15-, and ≥20-BCVA letter loss or BCVA loss to a level below driving eligibility threshold) versus sham over 12 months. Ophthalmology. Retina • 2024-11-15 • Phase III Randomized Trial | N = 225 | 82/100 | PMID 38719191 ↗ |
Avacincaptad Pegol Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.5200/unit (~$15.60/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $72.42 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 5 Anonymous DotMD Community Micro-Logs | $29.56 / mo | View logs ↓ |
| Hone Health Hormone & At-Home Biomarker Lab (Licensed Telehealth Cash Program) | State-licensed clinician review • ~3d mail fulfillment | $65.00 consult | Program details |
| Midi Health Perimenopause & HRT Clinic (Licensed Telehealth Cash Program) | State-licensed clinician review • ~2d mail fulfillment | $59.00 consult | Program details |
Avacincaptad Pegol Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Avacincaptad Pegol RxNorm Concept ID | RXN-82829002-2464 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.5200 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $72.42 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $29.56 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 88.00% Worth It (5 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Avacincaptad Pegol Patient Community, Cohort Filters & Dosage Logs
Cross-verified Avacincaptad Pegol (complement inhibitor) monograph synthesizing RxNorm RXN-82829002-2464, openFDA FAERS signals, and $29.56–$72.42 cash benchmarks.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Avacincaptad Pegol community threads and patient logs by age, biological sex, dosage, and treatment duration.